Inhibition of tumor necrosis factor alpha-induced prostaglandin E2 production by the antiinflammatory cytokines interleukin-4, interleukin-10, and interleukin-13 in osteoarthritic synovial fibroblasts: distinct targeting in the signaling pathways.
about
Biology of platelet-rich plasma and its clinical application in cartilage repairEpigenetic regulations of inflammatory cyclooxygenase-derived prostanoids: molecular basis and pathophysiological consequencesThe role of inflammatory and anti-inflammatory cytokines in the pathogenesis of osteoarthritis.Exercise increases interleukin-10 levels both intraarticularly and peri-synovially in patients with knee osteoarthritis: a randomized controlled trial.Synergistic activity of interleukin-4 and interleukin-10 in suppression of inflammation and joint destruction in rheumatoid arthritis.Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets.Anticytokine therapy for osteoarthritis.Effects over time of two platelet gel supernatants on growth factor, cytokine and hyaluronan concentrations in normal synovial membrane explants challenged with lipopolysaccharideBovine lactoferricin is anti-inflammatory and anti-catabolic in human articular cartilage and synoviumIL-4 and HDAC Inhibitors Suppress Cyclooxygenase-2 Expression in Human Follicular Dendritic CellsConcepts in gene therapy for cartilage repair.Prostaglandin E2 differentially modulates proinflammatory/prodestructive effects of TNF-alpha on synovial fibroblasts via specific E prostanoid receptors/cAMP.The therapeutic potential of interleukin-10 in neuroimmune diseases.Oxygen tension modulates the effects of TNFα in compressed chondrocytesJoint injury and osteoarthritis: soluble mediators in the course and treatment of cartilage pathology.Induction of secreted type IIA phospholipase A2 gene transcription by interleukin-1beta. Role of C/EBP factors.Regulatory role of cytosolic phospholipase A2 alpha in the induction of CD40 in microglia.A role for interleukins in ochronosis in a chondrocyte in vitro model of alkaptonuria.New developments in the treatment of osteoarthritis - focus on biologic agents.Regulation of osteoarthritis-associated key mediators by TNFα and IL-10: effects of IL-10 overexpression in human synovial fibroblasts and a synovial cell line.Prostaglandin E2 suppresses the differentiation of retinoic acid-producing dendritic cells in mice and humans.Autologous protein solution inhibits MMP-13 production by IL-1β and TNFα-stimulated human articular chondrocytes.Nimesulide, a preferential cyclooxygenase 2 inhibitor, suppresses peroxisome proliferator-activated receptor induction of cyclooxygenase 2 gene expression in human synovial fibroblasts: evidence for receptor antagonism.Characterization of the effect of interleukin-10 on silica-induced lung fibrosis in mice.Differential effects of IL-10 on prostaglandin H synthase-2 expression and prostaglandin E2 biosynthesis between spleen and bone marrow macrophages.Extracellular Vesicles from Adipose-Derived Mesenchymal Stem Cells Downregulate Senescence Features in Osteoarthritic Osteoblasts.Molecular basis of anti-inflammatory action of platelet-rich plasma on human chondrocytes: mechanisms of NF-κB inhibition via HGF.Effect of interleukin-4 on vascular endothelial growth factor production in rheumatoid synovial fibroblasts.
P2860
Q26860452-556DD9A8-328B-4759-BA7C-247EEA4BC357Q26862642-8ADA5A37-39B0-4710-8509-B209C0A1AC21Q33614316-B147BCE6-6121-43CC-8DFC-C9B014D79685Q34152911-31A99E7E-9DFC-43DD-BCC4-633B9991D54DQ34158420-B5C438B0-61D5-45BC-B9B0-3955234C0CC7Q34283578-2C073559-7AA6-49DB-9185-B2883743E4DFQ34452635-34FE3198-8EB6-4C00-8935-F7952C562A31Q35669327-FF14F440-5AB5-4F77-99BD-08400AD61AAAQ36295868-80EED89F-3C30-407C-8ED3-74C54D16E2F2Q36859953-4E9CF602-8305-4701-8A6A-1A3F966EC0C0Q37099568-78081811-0006-4729-B948-E83DE32884B6Q37357857-DD950FE5-D801-4D5E-BA0C-26DEEC8849DDQ37485007-31D46C5E-05D7-48CE-9476-D5A37CF11DA4Q37553559-00C1C4D0-9757-4C1D-94B8-295EC30C40EBQ37773271-F5433BD6-CFF1-4275-BFF0-59425A9ED83DQ38312676-C53BC9F4-A8D9-421F-911B-17947F5725A7Q38716917-3BD52888-00E4-4481-9A21-91F401855902Q38827337-C48512AF-A0CB-408F-92FE-BF514F9FDFA0Q38982848-E9587382-6C62-4807-BDFD-C6B5E2827706Q38996124-28FB41A2-902E-430D-BA19-5954B11A378AQ39491679-E9C2B76F-943E-4FC7-A5A1-33EB1D37759AQ42485864-FE44B6D1-D4CD-41A3-87DE-5662A537580FQ42517231-45E18602-5D23-483C-A352-3966DB333503Q44771552-5CB6392C-4D50-4E52-819D-59739D25E1A0Q45229023-60191214-1858-4ADA-B154-88C7C21CDE95Q47152710-836040BD-E77A-412A-B054-74CE4D966826Q52601576-78B27762-DA20-4377-BE9D-88ADA3F50D63Q53570948-3134DBEC-A686-470B-8849-11147DFDE37C
P2860
Inhibition of tumor necrosis factor alpha-induced prostaglandin E2 production by the antiinflammatory cytokines interleukin-4, interleukin-10, and interleukin-13 in osteoarthritic synovial fibroblasts: distinct targeting in the signaling pathways.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Inhibition of tumor necrosis f ...... ing in the signaling pathways.
@en
Inhibition of tumor necrosis f ...... ing in the signaling pathways.
@nl
type
label
Inhibition of tumor necrosis f ...... ing in the signaling pathways.
@en
Inhibition of tumor necrosis f ...... ing in the signaling pathways.
@nl
prefLabel
Inhibition of tumor necrosis f ...... ing in the signaling pathways.
@en
Inhibition of tumor necrosis f ...... ing in the signaling pathways.
@nl
P2093
P2860
P1476
Inhibition of tumor necrosis f ...... ing in the signaling pathways.
@en
P2093
J A Di Battista
J M Cloutier
J P Pelletier
N Alaaeddine
P2860
P304
P356
10.1002/1529-0131(199904)42:4<710::AID-ANR14>3.0.CO;2-4
P577
1999-04-01T00:00:00Z